Cet anticorps anti-KRT20 Monoclonal Souris (Clone KRT20-1993) (ABIN7871725) détecte spécifiquement KRT20 dans WB et IHC (p).
L’anticorps est réactif avec des échantillons de Humain.
KRT20
Reactivité: Humain, Souris, Rat
WB, IHC (p), IF (cc)
Hôte: Lapin
Monoclonal
1F10
unconjugated
Indications d'application
Optimal dilution of the CK20 antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
1 mg/mL in 1X PBS, BSA free, sodium azide free
Agent conservateur
Azide free
Stock
4 °C,-20 °C
Stockage commentaire
Store the CK20 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Antigène
KRT20
(Keratin 20 (KRT20))
Autre désignation
CK20
Sujet
This mAb recognizes an intermediate filament protein of 46 kDa, identified as Cytokeratin 20 (KRT20, CK20). KRT is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions. It has been detected in adenocarcinomas of the colon, stomach and biliary tract. Breast carcinomas are generally non-reactive.